Drugs · acquisition-cost intelligence
Fluticasone Propionate
· ingredient fluticasoneCorticosteroids· FLUTICASONE PROPIONATE .05 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.56876
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other fluticasone products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| fluticasone propionate | $0.35931 | −$0.20950 |
| 24 Hour Allergy Nasal | $0.68437 | +$0.11560 |
| FLOVENT DISKUS | $2.12 | +$1.55 |
| fluticasone propionate | $3.14 | +$2.57 |
| Arnuity Ellipta | $6.65 | +$6.08 |
| Fluticasone Propionate HFA | $12.55 | +$11.98 |
Medicare Part D coverage · CY2026
On 270 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 33% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.